🇺🇸 FDA

Intelligence Platform

Patents

Browse 20 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12343380

Expansion of TILs utilizing AKT pathways inhibitors

Iovance Biotherapeutics, Inc. · Granted Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12031157

Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses o

Iovance Biotherapeutics, Inc. · Granted Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12024718

Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses o

Iovance Biotherapeutics, Inc. · Granted Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11981921

TIL expansion processes using specific cytokine combinations and/or AKTi treatment

Iovance Biotherapeutics, Inc. · Granted Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11866688

Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses o

Iovance Biotherapeutics, Inc. · Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11667890

Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

Iovance Biotherapeutics, Inc. · Granted Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11401506

Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy

Board nf Regents The Inivercitvof Texas Cvctom · Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11384337

Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses o

Iovance Biotherapeutics, Inc. · Granted Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11357841

Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeuti

Iovance Biotherapeutics, Inc. · Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10760076

Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic dis

ProQR Therapeutics II B.V. · Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10709812

Biodegradable hydrogel for tissue expansion

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10415015

Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

Iovance Biotherapeutics, Inc. · Granted Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9976138

Methods and compounds useful in conditions related to repeat expansion

Ionis Pharmaceuticals, Inc. · Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9801911

Expansion of alloantigen-reactive regulatory T cells

The Regents of the University of California · Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700583

Methods and compositions for optimized expansion and implantation of mesenchymal stem cell

REGENERATIVE SCIENCES, LLC · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9095562

Methods and compositions for optimized expansion and implantation of mesenchymal stem cell

REGENERATIVE SCIENCES, LLC · Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368106

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7175838

Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment

The United States of America represented by the Department of Health and Human Services · Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6642049

Human brain endothelial cells and growth medium and method for expansion of primitive CD34

United States of America as represented by the Secretary of the Air Force · Granted Tue Nov 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6291652

Antibodies specific for proteins having polyglutamine expansions

The Regents of the University of California · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired